loader image

信誉平台开奖体彩中国游戏 飞艇一分钟官网直播 of epigenetic therapeutics to revolutionize medicine

DURECT harnesses epigenetic modulation to treat serious and life-threatening conditions, including acute organ injury and cancer. Our unique approach targeting dysregulated DNA methylation has the potential to change the course of disease and improve patients’ lives.

Epigenetic Modulation

Many types of acute organ injuries and cancers are associated with dysregulation of the epigenome, such as DNA methylation. There is vast potential for epigenetic therapies to address the underlying pathophysiology by mitigating epigenomic dysregulation and helping to improve cellular function or suppress tumor growth.1-3

Alcohol-Associated 飞飞艇手机app看开奖幸运 在线直播开奖网站 (AH)

Our first epigenetic modulator, larsucosterol, may have the potential to save the lives of patients with AH and become a new standard of care, based on outcomes from clinical trials to date.4 AH is an acute form of liver disease that accounts for about 158,000 hospitalizations in the U.S. per year5, and about 30% of patients die within 90 days of hospitalization.6

Clinical Trials

We are currently conducting a Phase 2b study (AHFIRM) in subjects with severe alcohol-associated hepatitis (AH) in more than 60 clinical trial sites across the U.S., EU, U.K., and Australia.

Scientists working in a lab

Partner with us

We welcome strategic partnerships to advance our collective goal to meaningfully impact patients’ lives and offer better therapeutic options.

Careers

Join our highly experienced, talented, and collaborative team as we strive to improve the 新幸运飞行艇官方开奖查询 在线官网查询计划历史记录 of human medicine with novel epigenetic therapies.

Press Releases

References

  1. Argemi J, Latasa MU, Atkinson SR, et al. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nat Commun. 2019;10(1):3126. doi:10.1038/s41467-019-11004-3
  2. Mazzone R, Zwergel C, Artico M, et al. The emerging role of epigenetics in human autoimmune disorders. Clin Epigenetics. 2019;11(1):34. doi:10.1186/s13148-019-0632-2
  3. Herman A, Occean JR, Sen P. Epigenetic dysregulation in cardiovascular aging and disease. J Cardiovasc Aging. 2021;1:10. doi:10.20517/jca.2021.16
  4. Hassanein T, McClain CJ, Vatsalya V, et al. Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis. Am J Gastroenterol. 2023;10.14309/ajg.0000000000002275.
  5. Data on File
  6. Hughes E, Hopkins LJ, Parker R. Correction: Survival from alcoholic hepatitis has not improved over time. PLoS One. 2018;13:e0195857.
Scroll to Top
友情链接: 体彩票查询国际体彩结果号吗 免费注册正规体彩平台网址游戏 2024澳洲体彩8开奖结果号记录历史 澳洲幸运10体彩开奖直播APP计划稳准结果 168飞艇计划全天稳定开奖幸运号码预测计算 168欧洲幸运8在线记录大全开奖数据开号快乐 幸运澳彩5统计开奖网站官网记录 手机新版APP计划文侩开号结果体彩飞艇结果 奥彩10幸运记录历史开奖号码查询 飞艇幸运授权开奖平台体彩预测网 全天人工统计+计划号码结果欧洲5行运